VioQuest Pharmaceuticals, Inc.
Other OTCTotal Valuation
VioQuest Pharmaceuticals, Inc. carries a market capitalization of 14,719.00, placing it among publicly traded companies globally. Its enterprise value stands at 867,410.55, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14,719.00 |
| Enterprise Value | 867,410.55 |
Share Statistics
VioQuest Pharmaceuticals, Inc. currently has 5.46M shares outstanding.
| Shares Outstanding | 5.46M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.04 |
| P/TBV Ratio | -0.30 |
| P/FCF Ratio | -0.24 |
| P/OCF Ratio | -0.24 |
Financial Position
VioQuest Pharmaceuticals, Inc. maintains a current ratio of 0.42, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.42 |
| Quick Ratio | 0.30 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -294.33 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
EBITDA reached -5.85M, while operating income came in at -7.05M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -7.05M |
| Pretax Income | N/A |
| Net Income | -10.11M |
| EBITDA | -5.85M |
| EBIT | -7.05M |
| Earnings Per Share (EPS) | -2.17 |
Balance Sheet
Total book value stands at -44.35M, with working capital of -1.56M providing operational flexibility.
| Cash & Cash Equivalents | 814,477.00 |
| Total Debt | N/A |
| Net Debt | -814,477.00 |
| Equity (Book Value) | -44.35M |
| Book Value Per Share | -9.23 |
| Working Capital | -1.56M |
Cash Flow
VioQuest Pharmaceuticals, Inc. produced -6.99M in operating cash flow over the past twelve months. After subtracting -2,850.00 in capital expenditures, free cash flow totaled -7.00M - equivalent to -1.46 per share.
| Operating Cash Flow | -6.99M |
| Capital Expenditures | -2,850.00 |
| Free Cash Flow | -7.00M |
| FCF Per Share | -1.46 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -193.47 |
| FCF Yield | -415.71 |
Stock Splits
VioQuest Pharmaceuticals, Inc.'s most recent stock split took place on April 30, 2008 with a 10:1 split ratio.
| Last Split Date | 4/30/2008 |
| Split Ratio | 10:1 |
Scores
VioQuest Pharmaceuticals, Inc. posts an Altman Z-Score of -73.95, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -73.95 |